Biotech Values

[urche]

MEDX

I have been accumulating MEDX shares for ~10 years,
LTBH, and now have a substantial profit on those shares.
IMO, the MEDX story may now just be beginning.

Congrats. You have seen some wild gyrations on your ride to profits. I also was a LT holder, but sold late last year. My reasoning was mostly related to the increasing complexity of the company, beyond my comfort zone in terms of understanding the company. I continue to like a lot of the prospects and deals individually. But collectively, I just don't know how to value a company with so many deals with so many companies on multiple continents.

I also am scared by the toxicity data on MDX-010, perhaps the most promising drug in its pipeline. I'm betting there will be a better time to buy back into MEDX when this issue is resolved. I agree with you that the 19% ownership of GENMAB is a very attractive both in terms of valuation and diversification.

Keep us posted on MEDX news.
Urche